Author

Vanivilasini Balachandran

Frederick National Laboratory for Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adam K. HedgeriD· 1 shared Ala M. ShaqraiD· 1 shared Celia A. SchifferiD· 1 shared Diego Suchenski Loustaunau· 1 shared Hiroshi MatsuoiD· 1 shared Jeong Min LeeiD· 1 shared Jonathan K. WattsiD· 1 shared Neşe Kurt YılmaziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adam K. HedgerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stability

Adam K. Hedger, Wazo Myint, Jeong Min Lee, Diego Suchenski Loustaunau, Vanivilasini Balachandran, Ala M. Shaqra, Neşe Kurt Yılmaz, Jonathan K. Watts, Hiroshi Matsuo, Celia A. Schiffer

This study designs and tests optimized oligonucleotide inhibitors for APOBEC3 enzymes, showing improved potency and nuclease stability compared to previous inhibitors.

Nucleic Acids Research · Mar 16, 2025Peer-reviewedBiochemistry